PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.64%
Negative revenue growth while JHX stands at 1.88%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-22.15%
Negative gross profit growth while JHX is at 1.66%. Joel Greenblatt would examine cost competitiveness or demand decline.
-41.01%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-43.79%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-45.82%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-48.24%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-48.22%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.47%
Share reduction while JHX is at 0.32%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.26%
Reduced diluted shares while JHX is at 0.30%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.05%
Dividend growth of 0.05% while JHX is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
79.61%
Positive OCF growth while JHX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
82.16%
Positive FCF growth while JHX is negative. John Neff would see a strong competitive edge in net cash generation.
-8.62%
Negative 10Y revenue/share CAGR while JHX stands at 169.53%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-22.98%
Negative 5Y CAGR while JHX stands at 62.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-36.73%
Negative 3Y CAGR while JHX stands at 26.03%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
113.92%
10Y OCF/share CAGR at 75-90% of JHX's 144.17%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
2.59%
Below 50% of JHX's 1192.20%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
18.08%
3Y OCF/share CAGR under 50% of JHX's 53.63%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
48.90%
Below 50% of JHX's 130.05%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-9.58%
Negative 5Y net income/share CAGR while JHX is 6905.49%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-51.67%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
131.60%
Below 50% of JHX's 1043.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
50.72%
5Y equity/share CAGR at 50-75% of JHX's 92.30%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
22.17%
Below 50% of JHX's 77.35%. Michael Burry suspects a serious short-term disadvantage in building book value.
140.45%
Stable or rising dividend while JHX is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
81.94%
Stable or rising mid-term dividends while JHX is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
53.18%
3Y dividend/share CAGR of 53.18% while JHX is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-24.95%
Firm’s AR is declining while JHX shows 19.13%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.39%
Inventory shrinking or stable vs. JHX's 5.10%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-1.19%
Negative asset growth while JHX invests at 2.01%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.28%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.49%
We cut SG&A while JHX invests at 4.20%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.